Chemokines and Viral-Induced Neurologic Disease
Chemokines and Viral-Induced Neurologic Disease
批准号:
8214533
负责人:
Thomas E Lane
金额:
$32.11万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-12-15 至 2015-11-30
关键词:
AcuteApoptosisAstrocytesBiologyCD4 Positive T LymphocytesCXC ChemokinesCXCL1 geneCXCL10 geneCXCR3 geneCXCR4 ReceptorsCell DeathCellsCessation of lifeChemotactic FactorsChronicChronic DiseaseClinicalCoronavirusDataDemyelinating DiseasesDemyelinationsDiseaseEncephalomyelitisEngraftmentEtiologyFundingGeneticGoalsHistologicHost DefenseHumanInfectionInfiltrationInflammatoryInterleukin-8B ReceptorLigandsLimb structureLinkLymphocyteMediatingModelingMononuclearMultiple SclerosisMurine hepatitis virusMusMyelinNervous System TraumaNeuraxisNeurogliaNeurologicOligodendrogliaOperative Surgical ProceduresParalysedPathogenesisPatientsPhysiologicalPopulationReceptor SignalingResearch ProposalsRoleSeveritiesSeverity of illnessSignal TransductionStem cellsStudy modelsSymptomsSystemT-LymphocyteTherapeuticViralViral hepatitisVirusVirus DiseasesWorkbrain cellchemokinechemokine receptormacrophagemigrationnerve stem cellneuroinflammationneurotropicneurotropic virusnovelnovel therapeutic interventionoligodendrocyte lineageoverexpressionpublic health relevancereceptorremyelinationrepairedresearch studyresponsesensitizing antigenvirus-induced demyelinationvirus-induced neurologic diseasewhite matter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term objective of this competitive renewal is to evaluate the functional role of chemokine and chemokine receptors in contributing to neurologic disease and repair following infection with a neurotropic murine coronavirus, mouse hepatitis virus (MHV). Infection of susceptible mice with MHV reproducibly results in an acute encephalomyelitis followed by a chronic demyelinating disease characterized clinically by ascending hind-limb paralysis and histologically by mononuclear cell infiltration into the central nervous system (CNS) accompanied by white matter destruction. Due to the similarities in clinical and histologic disease between MHV-induced demyelination and the human demyelinating disease multiple sclerosis (MS), the MHV system is considered an excellent model in which to study the underlying pathological mechanisms contributing to human demyelinating diseases such as MS. Similar to MS, both T cells and macrophages are thought to be important in contributing to white matter destruction. In addition, chemokine and chemokine receptors are expressed within the CNS of MS patients as well as MHV- infected mice indicating a prominent role in the pathogenesis of disease. Indeed, during the previous funding periods (initiated in 2000), we have defined functional roles for chemokines and chemokine receptors in regulating neuroinflammation that is involved in both host defense and demyelination in response to MHV infection by regulating lymphocyte and macrophage infiltration. The present proposal builds upon our previous work and offers the opportunity to define the functional role of chemokines and chemokine receptors in i) protecting oligodendrocytes (the myelin-producing cell of the CNS) from damage/death and ii) regulating the biology of engrafted neural progenitor cells e.g. positional migration and proliferation which contributes to axonal remyelination. Together, these studies will extend our current understanding of how chemokines and their receptors participate in protection and repair. Further, the data obtained from these experiments will identify potentially novel therapeutic approaches for treatment of MS as well as other human demyelinating diseases.
PUBLIC HEALTH RELEVANCE: The long-term goals of this research proposal are to use a viral model of the human demyelinating disease, multiple sclerosis (MS) to better understand how resident cells of the brain protect themselves from damage/death during ongoing disease as well as to define approaches to promote repair. It is our long-term goal to develop novel interventional treatments for limiting the severity of disease symptoms in MS patients as well as other human demyelinating diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FASEB's "The Translational Neuroimmunology Conference: From Mechanisms to Therapeutics."
-
批准号:10065269
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2020
-
负责人:Thomas E Lane
-
依托单位:
Defining mechanisms of disease and repair in a viral model of multiple sclerosis
-
批准号:10640816
-
项目类别:
-
资助金额:$87.41万
-
财政年份:2020
-
负责人:Thomas E Lane
-
依托单位:
Chemokines and Viral-Induced Neurologic Disease
-
批准号:10090528
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2020
-
负责人:Thomas E Lane
-
依托单位:
Human neural precursor cell-mediated therapy in a viral model of demyelination
-
批准号:10076583
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2020
-
负责人:Thomas E Lane
-
依托单位:
Human neural precursor cell-mediated therapy in a viral model of demyelination
-
批准号:8874463
-
项目类别:
-
资助金额:$57.03万
-
财政年份:2015
-
负责人:Thomas E Lane
-
依托单位:
Viral-induced demyelination and neural stem cell-mediated remyelination
-
批准号:8885924
-
项目类别:
-
资助金额:$30.98万
-
财政年份:2011
-
负责人:Thomas E Lane
-
依托单位:
Viral-induced demyelination and neural stem cell-mediated remyelination
-
批准号:8799481
-
项目类别:
-
资助金额:$7.41万
-
财政年份:2011
-
负责人:Thomas E Lane
-
依托单位:
Viral-induced demyelination and neural stem cell-mediated remyelination
-
批准号:8291218
-
项目类别:
-
资助金额:$31.65万
-
财政年份:2011
-
负责人:Thomas E Lane
-
依托单位:
Viral-induced demyelination and neural stem cell-mediated remyelination
-
批准号:8490463
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2011
-
负责人:Thomas E Lane
-
依托单位:
Viral-induced demyelination and neural stem cell-mediated remyelination
-
批准号:8152289
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2011
-
负责人:Thomas E Lane
-
依托单位:
Chemokine IP-10 and Viral-Induced Demyelination
-
批准号:6657924
-
项目类别:
-
资助金额:$18.27万
-
财政年份:2003
-
负责人:Thomas E Lane
-
依托单位:
Chemokines and Viral-Induced Neurologic Disease
-
批准号:6429940
-
项目类别:
-
资助金额:$24.49万
-
财政年份:2001
-
负责人:Thomas E Lane
-
依托单位:
Chemokines and Viral-Induced Neurologic Disease
-
批准号:6687717
-
项目类别:
-
资助金额:$24.39万
-
财政年份:2001
-
负责人:Thomas E Lane
-
依托单位:
Chemokines and Viral-Induced Neurologic Disease
-
批准号:7887983
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2001
-
负责人:Thomas E Lane
-
依托单位:
Chemokines and Viral-Induced Neurologic Disease
-
批准号:6620995
-
项目类别:
-
资助金额:$24.45万
-
财政年份:2001
-
负责人:Thomas E Lane
-
依托单位:
Chemokines and Viral-Induced Neurologic Disease
-
批准号:6829713
-
项目类别:
-
资助金额:$30.11万
-
财政年份:2001
-
负责人:Thomas E Lane
-
依托单位:
Chemokines and Viral-Induced Neurologic Disease
-
批准号:8389551
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2001
-
负责人:Thomas E Lane
-
依托单位:
Chemokines and Viral-Induced Neurologic Disease
-
批准号:8799945
-
项目类别:
-
资助金额:$28.53万
-
财政年份:2001
-
负责人:Thomas E Lane
-
依托单位:
Chemokines and Viral-Induced Neurologic Disease
-
批准号:7534975
-
项目类别:
-
资助金额:$29.59万
-
财政年份:2001
-
负责人:Thomas E Lane
-
依托单位:
Chemokines and Viral-Induced Neurologic Disease
-
批准号:6861286
-
项目类别:
-
资助金额:$5.56万
-
财政年份:2001
-
负责人:Thomas E Lane
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: